Coventry University Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Reading Featured PhD Programmes

Biochemistry (health care) PhD Projects, Programs & Scholarships

We have 18 Biochemistry (health care) PhD Projects, Programs & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 18 Biochemistry (health care) PhD Projects, Programs & Scholarships

Establishing a rationale for FGF23 modulation as a therapy in the critically ill patient

Research interests/description of main research theme. Everyone suffers at least one critical illness during their life. In the UK, 160,000 critically ill patients are admitted annually to intensive care units (ICU). Read more

Antibiotic resistance and biofilm formation in the WHO priority pathogen Acinetobacter baumannii

The McCarthy Lab at Brunel University London is excited to offer a fully funded PhD studentship to study how Acinetobacter baumannii can survive exposure to antibiotics and form a biofilm. Read more

Health Opportunity for Patient Empowerment in Gestational Diabetes (HOPE-GDM)

  Research Group: Chemistry and Biosciences
Gestational Diabetes is a temporary condition diagnosed at 24-28 weeks gestation, where the body is unable to maintain normal blood glucose levels due to insulin resistance during pregnancy. Read more

Re-purposing diabetes medicines to manage bleeding complications in myeloproliferative neoplasms.

Myeloproliferative neoplasms (MPNs) are a group of three related blood cancers in which the bone marrow overproduces one of the three cellular components of blood (erythrocytes, leukocytes and platelets). Read more

Modulation of platelet-mediated innate immune responses in chronic lymphocytic leukaemia

Chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia in the Western World. B-cell receptor-induced intracellular signals are critical for the survival of leukaemia cells and disruption of this pathway by the Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib is a highly effective CLL therapy. Read more

Identification of novel glucose-dependent alterations responsible for platelet dysfunction in Type 2 diabetes.

Type 2 diabetes mellitus (T2DM) is a growing global healthcare problem. Clinical findings suggest that more than 70% of patients with T2DM will die of cardiovascular diseases (CVDs) including heart attack and stroke. Read more

How does the vascular matrix environment influence platelet activation?

The platelet is a blood cell that plays a key role in the prevention of bleeding. For platelets to form a clot or thrombus effectively, they must rearrange their actin cytoskeleton to withstand high shear stress from blood flow in the arteries. Read more

New methods for ultra-high throughput proteomics for biomarker discovery

The ability to reliably measure protein concentrations in blood samples is critical for the identification of disease biomarkers to allow patients’ stratification and improve patient care. Read more

Filtering Results